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Key points
† Intraoperative
neuromonitoring can be
affected by specific
general anaesthetics.
† Changes in axonal
excitability of primary
sensory afferents with
propofol and sevoflurane
were investigated using
threshold tracking
technique.
† Both anaesthetics
similarly affected nerve
excitability to a small but
significant extent.
† Possible mechanisms
include direct anaesthetic
effects on neuronal
excitability and
temperature change due
to vasodilation.
Background. Intraoperative monitoring of neuronal function is important in a variety of
surgeries. The type of general anaesthetic used can affect the interpretation and quality
of such recordings. Although the principal effects of general anaesthetics are synaptically
mediated, the extent to which they affect excitability of the peripheral afferent nervous
system is unclear.
Methods. Forty subjects were randomized in a stratified manner into two groups,
anaesthetized with either propofol or sevoflurane. The threshold tracking technique
(QTRACw) was used to measure nerve excitability parameters of the sensory action
potential of the median nerve before and after induction of general anaesthesia.
Results. Several parameters of peripheral sensory afferent nerve excitability changed after
induction of general anaesthesia, which were similar for both propofol and sevoflurane. The
maximum amplitude of the sensory nerve action potential decreased in both groups
(propofol: 25.3%; sevoflurane: 29.5%; both P,0.01). The relative refractory period [mean
(SD)] also decreased similarly in both groups [propofol: 20.6 (0.7) ms; sevoflurane: 20.3
(0.5) ms; both P,0.01]. Skin temperature at the stimulation site increased significantly in
both groups [propofol: +1.2 (1.0)8C; sevoflurane: +1.7 (1.4)8C; both P,0.01].
Conclusions. Small changes in excitability of primary sensory afferents after the induction of
anaesthesia with propofol or sevoflurane were detected. These effects, which were non-
specific and are possibly explained by changes observed in temperature, demonstrate
possible anaesthetic effects on intraoperative neuromonitoring.
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Intraoperative monitoring of neuronal function is important
in a variety of surgeries. It is well known that the type and
concentration of general anaesthetic influence the quality
of neurophysiological signals recorded and hence their
interpretation.1 Clinical electrophysiological investigations
have so far considered the effect of general anaesthetics on
afferent axons as negligible, since axons are not usually con-
sidered as targets for these agents.2–4 In the peripheral
nervous system, a well-organized interaction of different sub-
types of voltage-gated ion channels defines the size, fre-
quency, and the speed of an action potential. Even a slight
shift in membrane potential of a nerve membrane can lead
to severely altered excitability, and thereby modulates the
information conveyed to the central nervous system.5 6 Propo-
fol and sevoflurane affect human voltage-gated ion channels
at clinically relevant concentrations, which therefore could
contribute to the effects on peripheral afferent excitability.7–10
The aims of this investigation were to test whether
propofol and sevoflurane have different effects on axonal
excitability of peripheral sensory afferents after induction of
general anaesthesia and how sensory nerve monitoring
might be influenced during anaesthesia.
We used the technique of threshold tracking, a diagnostic
tool which assesses axonal nerve excitability of myelinated
peripheral nerves in a non-invasive manner.11 – 13 In contrast
to conventional nerve conduction studies, threshold tracking
uses subthreshold currents to provide information about
nerve excitability and ion channel function.
Methods
Study subjects and randomization
Study subjects. The study was performed at the University
Hospital Zurich after approval by the local ethics committee
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(University Hospital Zurich, StV. 5-2008) in accordance with
the Declaration of Helsinki 2008 (registration number
NCT00696254, www.clinicaltrials.gov). All study subjects
gave written informed consent after careful instructions con-
cerning the study details. Specifically, they agreed on the
omission of premedication with a tranquilizer to exclude as
many unknown influencing factors as possible. Inclusion cri-
teria were: German-speaking patients undergoing surgery
under general anaesthesia; age 18–70 yr; weight 50–100
kg; and signed informed consent. Exclusion criteria were:
known peripheral neuropathy; diabetes mellitus; neuro-
psychiatric diagnosis; pregnant/breast-feeding women; con-
gestive heart disease; more than two out of four risk
factors for postoperative nausea and vomiting (PONV):
female, non-smoker, known PONV, and planned opioids
after operation; participation in other studies; and inability
of verbal expression. Forty subjects were randomized in a
stratified manner into two equally sized groups of 20 subjects
(Fig. 1). Induction was performed either with propofol or
sevoflurane.
Threshold tracking
We used a computer-assisted threshold-tracking program
(QTRAC, & Institute of Neurology, London, UK) to investigate
the excitability parameters of myelinated axons and ion
conductances in the median nerve.11 – 14 This technique
provides different information than conventional nerve
conduction studies which use supramaximal stimuli and
provide information about conduction velocity and ampli-
tude. The threshold-tracking technique uses subthreshold
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Fig 1 Enrolment and randomization of subjects recruited to the study.
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currents and provides information about excitability and ion
channel function.11 13 – 16
In the current study, we measured the excitability of
the median nerve stimulated transcutaneously at the wrist
(Supplementary Fig. S1A–C). The sensory nerve action
potential (SNAP) was recorded antidromically at Dig. II with
skin electrodes. The temperature at the stimulation site
was measured at the end of each measurement. We used
a recording protocol comprising five main parts: stimulus–
response curve, strength–duration relationship, recovery
cycle, threshold electrotonus, and current–threshold
relationship. Further information about the stimulation pat-
terns in our protocols, and how the measurements were
plotted and interpreted, is provided in the Supplementary
material, Methods and Figures.
Excitability measurements during anaesthesia
induction in patients
The study was performed in the anaesthesia induction room.
After completion of the first nerve excitability measurement
immediately before induction, anaesthesia was administered
exclusively with propofol or sevoflurane. No local anaes-
thetics, neuromuscular blocking agents, or opioids were
used until the second measurement was completed. Pulse
oxymetry (Draeger Infinity Delta Systems, Draeger Medical
Systems, Danvers, MA, USA) was measured using a probe
attached on a finger on the same arm used to measure
nerve excitability. Subjects were monitored with ECG, non-
invasive arterial pressure, and end-tidal gas analysis using
a KION anaesthesia workstation (KION workstation and
Maquet SC 7000 screen, Maquet-Siemens, Rastatt,
Germany). During the first measurement, baseline end-tidal
CO2 values were determined during quiet spontaneous res-
piration using a tight face mask. In order to reach a compar-
able depth of anaesthesia in both groups we aimed at a
stable bispectral index (BIS) value below 40 (BIS QuatroTM
sensors with Infinityw BISx Pod for Draeger; Software
version 1.03, Aspect Medical Systems, Inc., Norwood, MA,
USA). According to this parameter, we varied the target con-
centration of the propofol infusion (using a software-
controlled infusion pump with the pharmacological model
of Schnider and colleagues17 programmed to plasma con-
centration) and the inspiratory concentration of sevoflurane,
respectively. To minimize burning pain at the i.v. cannulation
site, the i.v. lactated Ringer’s infusion was infused at a
high flow rate until the patient was deeply sedated. For the
induction of anaesthesia with sevoflurane, we asked
subjects to breathe 100% oxygen for 3 min with a tightly
sealed oxygen mask. To begin anaesthesia, we opened the
sevoflurane vaporizer maximally (8%) and then decreased
the concentration gradually over the next few minutes. Con-
trolled manual ventilation was used to stabilize ventilation,
maintaining end-tidal CO2 values at baseline levels.
Before we recorded the second measurement, we
adjusted the concentrations of anaesthetics until subjects
were at steady state defined as: end-tidal CO2 at
baseline, haemodynamic stability, BIS consistently ,40,
constant calculated plasma concentration of propofol,
or difference in inspired and expired concentration of
sevoflurane ,0.3%.
The second nerve excitability measurement was then per-
formed at steady state. After the second measurement was
recorded, the study ended. Standard anaesthesia techniques
were carried out by the addition of a neuromuscular blocking
agent, opioid, and benzodiazepine where indicated. The
anaesthesia was continued according to institutional stan-
dards for the respective procedures.
Statistical analysis
All values are given as mean and standard deviation (SD) except
in Figures 3 and 4 and Supplementary Figures S2 and S3 where
standard errors of the mean (SEM) were used to visualize the sig-
nificance between groups. To analyse datawe used the software
QtracP (Version 3/4/2009,w Institute of Neurology, London, UK).
Data were tested for a normal distribution with the Lilliefors test
for normality. Gender was compared between groups using
Fisher’s exact test. Data before and after the induction of
anaesthesia within the same group were analysed with a
paired t-test. To compare excitability changes between the
two groups after the induction of anaesthesia, we used an
unpaired t-test. A Bonferroni correction was performed to
address multiple comparisons for the same variable. Thus, com-
parisons before and after the induction of anaesthesia within
the same group and between groups after intervention were
considered significant if P,0.013.
Results
Changes of general parameters during anaesthesia
We enrolled 17 female and 23 male subjects (Fig. 1), all of
whom completed the study. The characteristic data of the
studied population before starting anaesthesia are shown
in Table 1. After inducing anaesthesia, a comparable anaes-
thesia depth was achieved during the second measurement
in both groups [propofol: BIS 25 (8); sevoflurane: 27 (10);
P¼0.42]. The calculated plasma concentration of propofol
during the second measurement was 6.6 (1.3) mg ml21.
The end-expiratory sevoflurane concentration was 5.5
(1.3)%. The concentration of end-expiratory CO2 during and
after the induction of anaesthesia was not significantly
higher than the value during spontaneous breathing before
Table 1 Patient characteristic data. Values are presented as
number (n) or as mean (range) or mean (SD). There were no
significant patient characteristic differences between the groups
Propofol Sevoflurane
Age (yr) 43 (18–66) 39 (21–58)
Weight (kg) 77 (10) 72 (15)
Height (cm) 177 (7) 173 (11)
Female/male 6/14 11/9
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anaesthesia induction [propofol spontaneous: 4.5 (0.5) kPa;
anaesthetized: 4.6 (0.5) kPa, P¼0.09; sevoflurane spon-
taneous: 4.6 (0.4) kPa; anaesthetized: 4.6 (0.4) kPa,
P¼0.72]. There was no difference in the end-expiratory CO2
levels between the two groups before (P¼0.59) or after the
induction of anaesthesia (P¼0.84) (Fig. 2A). Skin temperature
at the stimulation site increased significantly in both groups
[propofol before: 32.5 (0.9)8C; after: 33.7 (1.1)8C, P,0.01;
sevoflurane before: 32.4 (1.2)8C; after: 34.1 (1.0)8C, P,0.01].
No difference existed between the groups after the induction
of anaesthesia (P¼0.17) (Fig. 2C). Mean arterial pressure
decreased significantly in both groups [propofol before: 101
(13) mm Hg; after: 81 (12) mm Hg, P,0.01; sevoflurane
before: 101 (14) mm Hg; after: 78 (12) mm Hg, P,0.01] but
was similar when compared between the groups (P¼0.55)
after the induction (Fig. 2D). Arterial pressure stabilized
after reaching equilibrium of anaesthetic depth, end-
expiratory CO2 concentration, stable BIS value, and stable
SO2. We did not need to take any pharmacological or other
measures in any of the subjects to stabilize arterial pressure.
Changes in excitability parameters during
anaesthesia
A summary of the excitability changes during the anaesthe-
sia induction is given in Tables 2 and 3. We observed signifi-
cant changes in only three excitability parameters after the
induction of anaesthesia.
First, the maximum amplitude of the SNAP decreased in
both groups significantly [before propofol: 39.9 (5.8) mV; after:
29.8 (4.4) mV, P,0.01; before sevoflurane: 47.1 (7.8) mV; after:
33.2 (5.3) mV, P,0.01], which corresponds to a decrease of
25.3% and 29.5%, respectively (Fig. 3). No difference was
observed between the two groups after the induction of anaes-
thesia (P¼0.44). As a result, the stimulus–response curve
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Fig 2 Ventilation parameters and temperature during anaesthesia induction. (A) End-expiratory CO2 remained stable after the induction of anaes-
thesia. We therefore assume that tissue pH was unaffected as well. (B) Peripheral oxygen saturation—measured with pulse oxymetry on the arm
where the recording was made—did not change after induction, indicating that no tissue ischaemia occurred at the stimulation and recording
sites. (C) The temperature at the stimulation site increased similarly and significantly during the induction with both general anaesthetics. (D)
Mean arterial pressure decreased significantly in both groups. The changes occurred in all subjects within a physiological range.
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shifted downwards on the stimulus–response plot. In the
group with sevoflurane, a distinctive shift of the curve to the
right was observed. For this group, this implies that more
current was needed to elicit the target action potential.
Secondly, during the early phase of the recovery cycle, the
curve shifted to the left in both groups (Fig. 4). Consequently,
the first intersection with the control threshold (the current
that is normally needed to elicit the targeted size of the
action potential, plotted as a straight line at 0% on the
y-axis) and representing the end of the relative refractory
period (RRP; see Supplementary Fig. S1C) occurred earlier.
The RRP decreased similarly in both groups [before propo-
fol: 4.4 (1.2) ms; after: 3.9 (1.1) ms, P¼0.01; before sevoflur-
ane: 4.0 (1.1) ms; after: 3.7 (1.2) ms, P,0.01]. No difference
was observed between the two groups after the induction
of anaesthesia (P¼0.28).
Thirdly, the overshoot after a hyperpolarizing conditioning
stimulus was less prominent after anaesthesia induction
[before propofol: 20.3 (2.9)%; after: 16.1 (3.4)%, P¼0.01;
before sevoflurane: 19.7 (6.2) %; after: 14.5 (5.6) %, P¼0.01;
Table 3]. ‘Overshooting’ represents an increase in current
required to reach the target threshold after the end of the
hyperpolarizing conditioning stimulus.15 It corresponds to
the activities of certain voltage-gated membrane ion chan-
nels (mainly slow potassium currents) which counteract the
changes of the membrane potential induced by the hyper-
polarizing conditioning stimulus. Consequently, we would
also expect a decrease in excitability at the end of the hyper-
polarizing stimulus [e.g. at TEh(90–100 ms)]. However, this
parameter remained stable after induction, which cannot
be conclusively explained at present.
Discussion
This study shows for the first time that general anaesthesia
affects excitability of primary sensory afferents determined
by threshold tracking. Using subthreshold currents rather
than supramaximal currents we could detect smaller
changes of nerve excitability properties than conventional
nerve conduction studies or somatosensory evoked
potential.
Table 2 Summary of measured parameters. Values are presented as mean (SD). P,0.013 is considered statistically significant and is emphasized
in bold. *P-values in parentheses represent comparison between ‘after propofol’ and ‘after sevoflurane’
Before
propofol
After propofol P-value Before
sevoflurane
After
sevoflurane
P-value P-value*
Latency (ms) 4.9 (0.5) 4.9 (0.4) 0.17 4.9 (0.4) 4.9 (0.4) 0.16 (0.85)
Peak response SNAP (mV) 39.9 (5.8) 29.8 (4.4) <0.01 47.1 (7.8) 33.2 (5.3) <0.01 (0.44)
Strength–duration time constant
(mS)
665 (135) 657 (134) 0.67 668 (184) 599 (265) 0.21 (0.40)
Rheobase (mA) 7.1 (1.6) 6.7 (1.5) 0.30 6.6 (1.6) 6.4 (1.6) 0.82 (0.73)
Relative refractory period (ms) 4.4 (1.2) 3.9 (1.1) <0.01 4.0 (1.1) 3.7 (1.2) <0.01 (0.28)
Superexcitability (%) 214.1 (5.8) 215.1 (5.0) 0.30 218.1 (10.2) 215.1 (7.5) 0.14 (0.93)
Subexcitability (%) 13.6 (6.5) 12.0 (4.0) 0.17 12.3 (3.7) 15.7 (20.9) 0.52 (0.44)
Temperature (8C) 32.5 (0.9) 33.7 (1.1) <0.01 32.4 (1.2) 34.1 (1.0) <0.01 (0.17)
CO2 (kPa) 4.5 (0.5) 4.6 (0.5) 0.09 4.6 (0.4) 4.6 (0.4) 0.72 (0.84)
BIS 98 (3) 25 (8) <0.01 97 (2) 27 (10) <0.01 (0.42)
SO2 (%) 99 (1) 99 (1) 0.32 99 (1) 99 (1) 0.41 (0.83)
MAP (mm Hg) 101 (13) 81 (12) <0.01 101 (14) 78 (12) <0.01 (0.55)
Table 3 Threshold electrotonus and current–threshold relationship. Values are presented as mean (SD). P,0.013 is considered statistically
significant and is emphasized in bold. *P-values in parentheses represent the comparison between ‘after propofol’ and ‘after sevoflurane’
Before propofol After propofol P-value Before sevoflurane After sevoflurane P-value P-value*
TEh(90–100 ms) (%) 125.0 (20.8) 119.0 (16.3) 0.28 120.4 (19.7) 122.3 (22.8) 0.68 (0.66)
TEd(10–20 ms) (%) 58.6 (7.8) 60.6 (5.2) 0.12 61.2 (6.1) 60.4 (8.9) 0.42 (0.89)
TEd(90–100 ms) (%) 42.7 (7.8) 44.6 (7.1) 0.17 44.6 (7.0) 45.6 (10.7) 0.37 (0.72)
TEh(10–20 ms) (%) 69.6 (12.9) 67.7 (6.9) 0.70 70.9 (9.0) 73.8 (16.2) 0.94 (0.19)
TEd(undershoot) (%) 21.9 (4.8) 21.9 (4.6) 0.88 21.1 (3.4) 19.0 (3.9) <0.01 (0.03)
TEh(overshoot) (%) 20.3 (2.9) 16.1 (3.4) <0.01 19.7 (6.2) 14.5 (5.6) <0.01 (0.36)
Resting I/V slope 0.6 (0.1) 0.6 (0.1) 0.11 0.6 (0.2) 0.6 (0.2) 0.06 (0.50)
Minimum I/V slope 0.3 (0.1) 0.3 (0.1) 0.65 0.3 (0.1) 0.3 (0.1) 0.70 (0.90)
Hyperpol. I/V slope 0.7 (0.5) 2.2 (4.8) 0.84 0.4 (0.1) 0.6 (0.4) 0.29 (0.41)
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Possible intrinsic effect of anaesthetics
on excitability parameters
Previous studies have shown that both propofol and
sevoflurane alter nerve excitability at clinically relevant con-
centrations by modulating voltage-gated sodium channels,
voltage-gated potassium channels, or both in the central
and peripheral nervous system.7 8 10 12 18 In our investi-
gation, parameters sensitive to changes in membrane
potential remained almost unchanged after the induction
of anaesthesia. However, we found three parameters that
could be explained by an intrinsic effect of the general
anaesthetics on peripheral nerve excitability.
(i) The RRP was shorter: investigations with the same
threshold-tracking technique have shown that blocking
sodium channels results in a shift of the recovery cycle
curve to the left combined with a decrease in
superexcitability in sensory afferents.19 20 The latter
parameter, however, remained unchanged in our
investigation.
(ii) The amplitude of the maximum peak response
decreased; the size of a compound action potential
decreases by temporal dispersion caused by different
underlying mechanisms: differential slowing of indi-
vidual fibres, availability of the largest-diameter
fibres, and changes in the amplitude of individual
spikes.21 22 An intrinsic blocking of voltage-gated
sodium channels could have led to a reduced size of
peak response.23 However, this conclusion could only
be drawn in stable recording conditions. In our study,
the temperature at the stimulation site changed sig-
nificantly and, therefore, was likely to have an impor-
tant influence on the response size (see below).
(iii) We observed no change in latency: according to the
previously published data, we would expect a
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Fig 3 Peak response and latency changes. (A) The stimulus–response curve of the maximum sensory nerve action potential showed a down-
wards shift on the y-axis after the induction of anaesthesia with both general anaesthetics. No significant shift occurred on the x-axis, indi-
cating that the current strength needed to elicit maximum response was not affected. (B) The size of the maximum peak response was
significantly smaller for both anaesthetics but no difference was found between the two. The latency of the peak response was not affected
in either group. Circles indicate the mean current needed to elicit 50% of the maximum peak response. Error bars are SEM.
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pronounced decrease in latency, hence an increase
in conduction velocity, of about 3% caused by the
temperature change detected at the stimulation
site.24 But, the latencies remained unchanged
before and after the induction of anaesthesia. This
could imply that the faster kinetics of the voltage-
gated ion channels induced by the higher tempera-
ture was counteracted by a partial block of sodium
channels.
None of the above findings, however, is specific for
an intrinsic effect of the investigated general anaesthetics
on nerve excitability. Skin temperature at the stimulation
site increased significantly and, therefore, temperature
must be taken into account when interpreting these
results.
Role of temperature in changes in excitability
during anaesthesia
Temperature variation results in several changes in periph-
eral nerve excitability. Although in our study, temperature
differences between the first and the second measurements
were small, they were significant, probably due to a decrease
in sympathetic activity,25 resulting in vasodilation with an
increase in skin temperature.26 27 Temperature changes
affect all nerve excitability indices measured with threshold
tracking to some extent.28 The most prominent effect is a
decrease in refractoriness with increasing temperature.24 28
Our results are in line with this finding, reflected by the left-
ward shift of the recovery cycle curve, indicating a shortening
of the RRP. The underlying mechanism is a faster recovery
from inactivation of voltage-gated sodium channels at
higher temperatures.29
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Increased temperature also leads to a linear increase in
nerve conduction velocity.30 31 According to the previously pub-
lished data, we would expect a decrease in latency of about 3%
caused by the temperature change measured in our study.24
However, latencies were not different, nor did we find a linear
relationship of refractoriness and latency changes described
by Burke and colleagues.28 Therefore, we might assume that
the temperature change of 1.58C was too small to affect
excitability. Also, temperature changes affect conditioned
evoked potentials much more than unconditioned potentials.28
Refractoriness—in contrast to conduction velocity—was
measured with a supramaximal conditioning stimulus; there-
fore, our findings would fit well with this theory.
In our investigation, the size of the compound action
potential decreased after the induction of anaesthesia
with both anaesthetics. The effect of temperature on the
size of the compound action potential is more complex to
explain. On the one hand, the compound action potential
is sensitive to temporal dispersion of individual action
potentials of nerve axons. Increasing the temperature,
therefore, decreases the amount of dispersion of the com-
pound action potential and results in greater amplitude.31
On the other hand, an increase in temperature decreases
the duration of the action potential and leads to a smaller
action potential. Hence, the measured size of the action
potential at higher temperatures is a combination of both
effects. In a study by Kiernan and colleagues24 of motor
nerve fibres, peak amplitude increased only when raising
the temperature from 32 to 358C, although the overall
effect of temperature increase was a decrease of SNAP.
Similar non-linear relationships between SNAP size and
temperature changes have been described by Ludin and
Beyeler.30
Anaesthesia depth, ventilation, and haemodynamic
changes did not affect excitability
Our study endpoint was to compare the effect on peripheral
nerve excitability of two different general anaesthetics at an
equipotent dosage. Clinically, at first glance, these concen-
trations appear to be high because propofol and sevoflurane
are usually used in combination with co-anaesthetics (e.g.
opioids or benzodiazepines). In our study, however, patients
were not premedicated, and until the end of the second
measurement, we did not use any other co-medication. Con-
sequently, the target plasma concentrations of propofol and
end-expiratory sevoflurane concentrations required to reach
BIS values below 40 were higher.
Several parameters which could have influenced nerve
excitability were controlled very closely. Anaesthesia induc-
tion was performed exclusively by one senior anaesthesiolo-
gist and normoventilation was achieved throughout the
recording period. We cannot fully exclude alveolar hypercap-
nia. However, according to the previously published data,
strength–duration time constant would probably be the
most sensitive parameter to detect hypercapnia.32 Since
this parameter also remained unchanged we may assume
that alveolar PCO2 did not influence our measurements. The
depth of anaesthesia was equivalent in both groups and
therefore contributed comparably—if at all—to the
measured excitability changes assuming conserved
mechanisms.
Although the induction of anaesthesia caused a signifi-
cant decrease in arterial pressure values, they never
reached low physiological values. Furthermore, the oxygen
saturation in the same arm remained stable. Therefore, we
are sure that the perfusion pressure at the stimulation site
was high enough to prevent hypoperfusion or hypoxaemia
of the nerve and did not cause previously described
changes in excitability.33 – 35
Conclusion
The induction of general anaesthesia with propofol and sevo-
flurane resulted in a change of excitability of primary sensory
afferents. These changes were subtle at relatively high con-
centrations of the anaesthetics. A direct effect of general
anaesthetics on excitability could not be excluded but was
minimal at most; it is more likely that the significant
changes we found were caused by an increase in tempera-
ture at the site of stimulation. Further investigations are
needed to elucidate the differentiation between these two
mechanisms. However, our findings demonstrate possible
interference by general anaesthetics during intraoperative
neuromonitoring of the peripheral nervous system.
Supplementary material
Supplementary material is available at British Journal of
Anaesthesia online.
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